INCLINE VILLAGE, Nev.,
Feb. 25, 2020 /PRNewswire/
-- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI)
announces that Dominique Monnet,
PDL's president and chief executive officer, will present at the
Cowen and Company 40th Annual Health Care Conference on
Tuesday, March 3, 2020 at
10:40 a.m. Eastern time (7:40 a.m. Pacific time). The conference is being
held at the Boston Marriott Copley Place.
To access the live and subsequently archived webcast of the
presentation, visit the Company's website at https://www.pdl.com/,
go to the Investor Relations section and select "Events &
Presentations." Please connect to the website at least 15 minutes
prior to the presentation to allow for any software download that
may be necessary. The archived webcast will be available for at
least seven days following the presentation.
About PDL BioPharma, Inc.
Throughout its history,
PDL's mission has been to improve the lives of patients by aiding
in the successful development of innovative therapeutics and
healthcare technologies. PDL BioPharma was founded in 1986 as
Protein Design Labs, Inc. when it pioneered the humanization of
monoclonal antibodies, enabling the discovery of a new generation
of targeted treatments that have had a profound impact on patients
living with different cancers as well as a variety of other
debilitating diseases. In 2006, the Company changed its name to PDL
BioPharma, Inc.
As of December 2019,
PDL ceased making additional strategic transactions and
investments and is pursuing a formal process to unlock the value of
its portfolio by monetizing its assets and ultimately distributing
net proceeds to shareholders.
For more information please visit https://www.pdl.com/.
NOTE: PDL, PDL BioPharma, the PDL logo and associated
logos and the PDL BioPharma logo are trademarks or registered
trademarks of, and are proprietary to, PDL BioPharma, Inc. which
reserves all rights therein.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/pdl-biopharma-to-participate-in-the-cowen-and-company-40th-annual-health-care-conference-301008917.html
SOURCE PDL BioPharma, Inc.